chrisvoncsefalvay/vaers-outcomes huggingface dataset:
3-30-21 5:55PM RASH TO LT ARM AT INCJECTION SITE. BENADRYL 50MG PO GIVEN, NO SOB. A/O, PINK, W/D, RESP REG WITH EASE.6:17PM DECREASED RASH NOTED/LESS PINK. 6:21PM HOME WITH PARENTS. AMBULATORY, GAIT BRISK AND STEADY. NO ACUTE DISTRESS. 3-31-21 8:30AM PATIENT MOM STATES 'RASH IS GONE NOW'.
This case was reported by a other health professional via sales rep and described the occurrence of myalgia in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, 10 hrs after receiving SHINGRIX, the patient experienced myalgia, fever, shivering, nausea and feeling bad. The patient was treated with analgesic, nos (Analgesic). On an unknown date, the outcome of the myalgia, fever, shivering, nausea and feeling bad were recovered/resolved. The reporter considered the myalgia, fever, shivering, nausea and feeling bad to be related to SHINGRIX. Additional details were provided as follows: This case was reported by medical assistant (MA), who herself was patient. The patient's date of birth was unknown. The age at vaccination was not reported. The patient received SHINGRIX at 4 pm. The patient woke at 2 am as she was feeling bad and experienced myalgia, fever (103 degree F), shivering, nausea. The patient felt very bad and was taking analgesics. She had to call in sick to work. The reporter felt this all was caused by SHINGRIX. The reporter did not agree to follow up from GlaxoSmithKline. This was all the information the reporter had.
Patient came in and got FLUBLOK QUAD 2018/19, in the morning patient received flu shot, came back around 4:45 pm with rash around the injection site and warm to touch, slight swelling of the area around injection site. Patient reported not feeling well and very itchy around the injection site. Pharmacist asked patient to go and see doctor. Patient came back with diagnosis of allergic reaction, was given rx for prednisone 20 mg daily for 2 days and BENADRYL OTC.
She stated that she had a cyst develop on her arm from the pneumonia vaccine that had to be surgically remove; anaphylactic reaction to Pneumovax; This spontaneous report as received from a 68 years old female retired medic via Pfizer referring to herself. The patient had a significant allergies to food related, nitrate plants and medications. The patient was allergic to tomato, potato, eggplant, cayenne, chili pepper, paprika, whole wheat, egg albumin, aluminum, baclofen, diphenhydramine hydrochloride (BENADRYL), benzene (BENZOL), clindamycin, and so on. The patient had an allergic reaction to egg component of influenza virus vaccine (unspecified). The patient was immunocompromised and had multiple sclerosis. The patient was taking immunosuppressants and interferon beta-1a (AVONEX).  In approximately January 2011 (reported as 10 years ago), the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (strength, dose, route, lot# and expiration date were unknown) for prophylaxis.  In approximately January 2011 (reported as 10 years ago), the patient had an anaphylactic reaction to pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23). The patient received self medicating with an antihistamine. On an unknown date, the patient had a cyst develop on her arm from the pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) vaccine that had to be surgically removed. The outcome of anaphylactic reaction and cyst was unknown. The reporter considered the causal relationship between anaphylactic reaction and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was related. The causality assessment between cyst and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was not reported.  Upon internal review, anaphylactic reaction was determined to be medically significant.
left arm in which the vaccine was administered began to swell and experienced pain in her chest. Also, a rash began to develop around the injection site. Patient instructed to take Benadryl and Motrin. Instructed to go to urgent care as she later stated she has a pork allergy (gelatin in vaccine is of porcine derivate)
Presumed SIDS approximately 20 hours after vaccine administration. An unofficial coroners report confirmed this.  Follow up 09/11/2000: "Anthrax adsorbed/Michigan DPH Lot # 1 FAV 030."
Altered taste; Tongue burning; Nausea; Shakes; Chills; Injection site redness; Pain; Weakness; Extreme fatigue; This is a spontaneous report from a contactable nurse, the patient. A 54-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0196) via an unspecified route of administration in the left arm on 14Jun2021 at 12:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included cetirizine hydrochloride (ZYRTEC) and multivitamin (MANUFACTURER UNKNOWN); both for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the left arm on an unknown date in May2021 at 16:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. The patient previously also received methylparaben (MANUFACTURER UNKNOWN) for unknown indication from an unknown date and experienced drug allergy. On 14Jun2021 at 12:30, the patient experienced altered taste, tongue burning, nausea, shakes, chills, injection site redness, pain, weakness and extreme fatigue. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events shakes, chills, injection site redness, pain, weakness and extreme fatigue was resolved on an unknown date in Jun2021 whereas events altered taste, tongue burning and nausea was not resolved at the time of this report on 21Jun2021.
Swelling at injection sight spreading to elbow. Hot, raised, starts out a solid knot and becomes smaller clusters of knots under the skin. At the end of the treatment by antibiotic, skin peeled in areas and left dark markings of some of the skin area that was infected.
Was c/o " a lot of pain" in left shoulder 04/01/2002. 04/02/2002 after school, mother noted red, heat, edema left shoulder.
first dose of Shingrix in November of 2020 / has not yet received the second dose; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date in November 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: This case was reported by patient herself. The age at vaccination was not applicable for this report. Till the time of reporting the patient did not receive second dose, which led to incomplete course of vaccination. The reporter did not consent to follow up.
Itchy rash on trunk, extremities and head. 2 doses of Benadryl was needed within 24 hours after onset of rash.
I started having numbness and tingling in my hands and arms about a day after my second dose of the vaccine. I'm still having numbness and tingling in my arms and especially my fingers since February. It's May now and it hasn't stopped. It makes it hard to pick up objects sometimes and I drop things unexpectedly. I have no grip and it interferes with my life and work.
Pt admitted to hospital  Pt is a 50 year old woman with a PMH of newly diagnosed breast Ca (this year) -s/p initial chemo and just received second dose of Taxol. She is FU with Dr. She received her second dose of Covid vaccine last Tuesday. On Friday, she developed a fever with chills. She then developed cough and diarrhea.  Fevers have persisted and she feels weak and very fatigued.  Diarrhea is better since Monday. Cough is still present but is some better.  She feels a little dyspneic, has no appetite but denies any NV . No melena or HC.   Prior to her breast cancer, she had no PMH.  She is alert and in no acute distress but appears ill and tired.  Sats remain OK while she is talking - on RA.  Exam as noted. Mucosa dry. Port L ant chest is intact with  No erythema or sts.  Lungs with good bilat BS . Coarse crackles R base. NO wheezes.  CV RRR wom. Abd soft, no tenderness. extr wo edema or rash.  Labs and xray as detailed in note.  vss BP 145/81  Pulse 94  Temp 99.2 °F (37.3 °C)  Resp 19  Ht 5' 4"  Wt 245 lb  SpO2 94%  BMI 42.05 kg/m2 Assessment and POC and as detailed in Resident note: --  Acute febrile illness, multisystem complaints cw viral illness,  likely Covid.  Inflammatory markers high.  Lactate negative. PCR sent. IF negative, will send viral panel. HOlding abx for now with close observation and will start for CAP if sx change.  Blood cultures obtained. UA negative.  Supportive symptomatic care with close monitoring for potential for deterioration requiring acute intervention.  --  Breast cancer  --  Obesity with high BMI  Due to medical issues in the assessment and plan, continued hospitalization will be required.  Assessment and plan, medications, test results, discharge plans, follow up and plan of care as detailed in Dr. note and discussed with patient and with resident.
tired; achy; total exhaustion; muscle fatigue; joint pain; joint tenderness; overall weakness; This is a spontaneous report from a contactable consumer or other non hcp.     A 49-years-old female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection (Batch/Lot number was not reported), dose 2 via an unspecified route of administration, administered in Arm Left on 03Apr2021 09:15 as 2nd dose, single for covid-19 immunisation.Medical history included irritable bowel syndrome, spinal fusion surgery. Concomitant medication(s) included naproxen sodium (ALEVE).The patient had not known allergies.The patient did not receive any other vaccine in four weeks. Prior to vaccination patient was not diagnosed with COVID. Post vaccination patient did not test for COVID. It was Reported that, the week following 2nd dose, tired &achy. Beginning 3 weeks after 2nd dose total exhaustion,muscle fatigue, joint pain, joint tenderness,and overall weakness which has persisted for more than 4 weeks. The events achy, total exhaustion on,muscle fatigue, joint pain, joint tenderness,overall weakness on 24Apr2021 12:00 with outcome of not recovered.Therapeutic measures were taken Iron & B12 supplements and Tylenol as a result of tired (fatigue), achy (pain), total exhaustion (fatigue), muscle fatigue (muscle fatigue), joint pain (arthralgia), joint tenderness (arthralgia), overall weakness (asthenia).  Follow-up actions required. Further information requested.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 47-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 29Apr2021 as dose 1, single (Lot number: EW0167), in left arm, on 20May2021 as dose 2, single (Lot number: ER8736), in left arm and on 20Dec2021 as dose 3 (booster), single (Lot number: 3302580) at the age of 46 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing), notes: other medical history: Asthma; "Type 2 Diabetes" (unspecified if ongoing), notes: other medical history: Type 2 Diabetes; "Hypertension" (unspecified if ongoing), notes: other medical history: Hypertension; "known allergies: Penicillin" (unspecified if ongoing), notes: known allergies: Penicillin. Concomitant medication(s) included: SYMBICORT; METFORMIN. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of vaccination failure, covid-19.
The patient got shortness of breath for about 5 minutes. She was feeling difficulty in breathing. It lasted about 5 minutes.
10/15: (L) arm felt stiff and sore. 10/16: Couldn't move arm and has been bothering patient ever since. Kept getting Charlie horse constantly at night and would wake her up in pain. 10/27 doctor visit did not give any treatment. Doctor did not give anything. Thought it was related to other health problems. 11/2 doctor prescribed cortisone/steroids but did not take it. No longer has charley horse but could not sleep well because of the pain. Cant trust movement in arm would drop things. Never had problem before with vaccines. Not sure it hit a nerve or had a reaction. Experiencing problems in arm; joint pain, limited movement, pain from shoulder down to arm. Arm goes to sleep, not as painful as charley horse but still is nerve racking because cant trust movement in arm. Had doctor apt on 11/30 and another scheduled for 12/30.
Blister on the left arm at site of injection. Patient did not report any treatment but he was concerned about the reaction after receiving the shot.
pt recvd vax & exp unspecified rxn which required her to recv med tx & miss time from work;
When I woke up at 6:40 am My hip joints had about a number 7 level of pain.  I could not stand straight or easily walk.  I went to bed and at about 9:30am the pain had gone down to about number 4. It has remained at that level whether standing, waking, or sitting.
Pt received her Fluzone HD and stayed in the store for about 20 minutes to shop.  She came back about 20 minutes after the IMZ and told me she had some pain and a little bit of swelling.  She said it feels like a knot.  I told her to go home and ice.  I called her about 20 minutes later and she is doing ok.  It has not gotten worse.
Face started to look like she had a stroke on or near Monday evening 11/26/2012 but I wasn't sure. She was complaining of tooth and tongue pain and then no pain a day later. I thought she was having a tooth ache or teeth coming in. Then I noticed she would not eat or drink because of poor muscle movement and facial control. She drooled when she drank and could barely drink from a straw - partial facial paralysis.
The date initially provided (5/18) is associated with my mother?s first vaccine shot of Pfizer, but I experienced side effects on 5/24. The side effect I experienced was having my menstrual cycle to resume with spotting after it had ceased the week prior and I should have been in my ovulation cycle. For over a decade, I?ve used an app to track my cycle. At the time of this side effect, I was not vaccinated. Fast forward to receiving my first vaccine shot of Pfizer in my right arm on 7/30 administered at a hospital, my cycle was again disrupted. This time, my cycle resumed two weeks early (but it was light and lasted for five days) followed by an ovulation cycle. My cycle has been completely upended, and per my calendar, I?m eight days late.
2 days after first injection developed rash on face, over eyes and nose. After 2 injection developed rash on face near nose, and top lip swollen couple hours after injection. Also developed rash in left armpit and what looks like pimples under armpit and on my side, almost 2weeks later. Still have that rash as of today.
Patient came in received flu shot- signed all necessary documents. Patient called today on 9/23 stating that she could not lift her arm and that she wanted every single contact we have as she is seeking a lawyer. Spoke to Pharmacy Manager regarding incident.
Client states she felt a burning sensation on her Rt arm during the night and scratched her arm. In the morning when she woke up she noted 2 blisters on her Rt arm (approximately 5 inches below the injection site).
Approximately 30 secs after vaccine was administered, pt became light headed and dizzy. Nurse had pt lay flat and administered ice pack to back of neck. Pulse normal. Ten minutes later, nurse asked how pt was feeling, she complained of still being dizzy and that both arms felt numb/ tingly. Pulse rechecked, left arm slower than right. Both of patient's arms began to shake. Red blotches noted on patient's chest and neck. The nurse practioner in the office was called and came to eval patient. Nurse practioner ordered Benedryl 25mg to be given.
The patient reports receiving the Johnson & Johnson Covid 19 vaccine in early April 2021. The patient presented to the local emergency department on 4/28/21 and had suffered an ischemic stroke.  Patient had been laying on the floor for a few days prior to hospitalization. Also had traumatic rhabdomyolysis. He was discharged from the hospital and now recovering at a skilled nursing facility.
Patient stated she is going to the hospital 4/26/2021 4:15 pm
adverse event; Initial information received on 28-May-2020 regarding an unsolicited valid non-serious case received from a consumer.  This case involves a patient with unknown demographics who experienced adverse event (adverse event), while patient received MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA].  Medical history, medical treatment, vaccination and family history were not provided. List of concomitant medication not reported.  On an unknown date, the patient received a dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [lot number and expiry date not reported] via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious adverse event (adverse event) (unknown latency) following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE.  Details of laboratory data not reported.  Final diagnosis was adverse event.  It was not reported if the patient received any corrective treatment.  The event outcome was unknown for adverse event.  There will be no information available on the batch number for this case.
Pain at the place of the injection, bothered during the night as I was rolling in the bed. Fever, feeling too hot and too col, chills, fatigue. Abdominal cramps, although my period doesn't start until the 19th.
The pt complained of weakness, dizziness, fatigue, cold and flu like symptoms for 7-10 days. Still complains of dizziness.
malaise; This is a spontaneous report received from a contactable reporter(s) (Pharmacist).  A 69-year-old male patient received COVID-19 Vaccine - Manufacturer Unknown, as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and on 20May2022 as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MALAISE (non-serious), outcome "recovered".  Additional information: 69 years old male patient received 2nd booster experienced malaise for 4 hours after immunization. Recovered to baseline after resting without incident. No fever experienced. Similar previous reaction to covid vaccine. Event took place after use of product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Ataxic gait 1 wk after immunization. Progressed to (L) hip flexor weakness and (R) leg paresthesias. Admitted for eval. Imaging negative. LP (+) protein; consistent with Guillain Barre.
abdominal rash, trunk hives, severe right thigh pain, burning skin, chest pressure
Raised welt on arm, first reported on 10/11/19, vaccine given on 10/9/19
Tongue got very patchy like a strawberry; Felt a lot of pressure in chest; Left upper right chest up to neck, to back and all the way down; Has inflammation; Pain; Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of STRAWBERRY TONGUE (Tongue got very patchy like a strawberry), CHEST DISCOMFORT (Felt a lot of pressure in chest), CHEST PAIN (Left upper right chest up to neck, to back and all the way down), INFLAMMATION (Has inflammation) and PAIN (Pain) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 from November 2020 to January 2021. Concurrent medical conditions included Iodine allergy, Shellfish allergy, Drug allergy (Gabapentin, Duexis, steroids, anti-inflammatories, tramadol, meloxicam) and Fibromyalgia.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced STRAWBERRY TONGUE (Tongue got very patchy like a strawberry), CHEST DISCOMFORT (Felt a lot of pressure in chest), CHEST PAIN (Left upper right chest up to neck, to back and all the way down), INFLAMMATION (Has inflammation), PAIN (Pain) and VACCINATION SITE PAIN (Pain at injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at an unspecified dose and frequency and PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, STRAWBERRY TONGUE (Tongue got very patchy like a strawberry), CHEST DISCOMFORT (Felt a lot of pressure in chest), CHEST PAIN (Left upper right chest up to neck, to back and all the way down), INFLAMMATION (Has inflammation), PAIN (Pain) and VACCINATION SITE PAIN (Pain at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment information included Benadryl and Tylenol. Action taken with mRNA-1273 in response to the event was unknown
Recurring pulsatile tinnitis in right ear, which seems to be off and on daily since noticed on 5/9/21.